Heart Failure POC & LOC Devices Market set to reach $401.91 million by 2032.

From GlobeNewswire: 2024-12-07 08:00:00

The Heart Failure POC & LOC Devices Market was valued at USD 95.94 million in 2023, expected to reach USD 401.91 million by 2032, growing at a CAGR of 17.26%. Rising demand for early heart failure detection and technological advancements in diagnostic devices are key growth drivers.

The market is witnessing significant growth due to increased demand for early detection and continuous monitoring of heart failure patients. Point-of-care and lab-on-chip devices are crucial for real-time diagnostic results, adopted in various healthcare settings for timely diagnosis and treatment.

Integration of AI and ML in POC and LOC devices enhances predictive capabilities, offering a cost-effective solution for patients to monitor their condition outside clinical settings. Growing awareness of heart failure and advancements in diagnostic technology contribute to better management, potentially reducing hospitalizations and improving survival rates.

Proteomic testing led the market in 2023, accounting for 53% of total market share. Microfluidics technology dominated due to miniaturization of diagnostic tests. North America leads the market, with Europe and Asia Pacific also showing significant growth potential. Emory University Hospital made headlines in November 2024 for a groundbreaking surgical implantation. In August 2024, researchers developed a point-of-care electrochemical biosensor prototype for heart failure screening. This device can measure two biomarkers for heart failure from a drop of saliva in just 15 minutes, improving access to screening, especially in underserved areas. In April 2024, Roche Diagnostics India launched its Heart Failure Test for Diabetics on a point-of-care device, aiming to improve early detection and intervention for diabetic patients with heart failure.

The Heart Failure POC & LOC Devices market is expected to experience significant growth due to the increasing demand for early diagnosis, a shift toward decentralized care, and technological advancements. Innovations in test types and technologies, including proteomic and genomic testing, microfluidics, and array-based systems, will continue to drive expansion. Recent product launches highlight the industry’s commitment to providing faster, more accessible diagnostics for heart failure patients worldwide.



Read more at GlobeNewswire: Heart Failure POC & LOC Devices Market to Hit USD 401.91